ATE302011T1 - PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN - Google Patents

PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN

Info

Publication number
ATE302011T1
ATE302011T1 AT99968140T AT99968140T ATE302011T1 AT E302011 T1 ATE302011 T1 AT E302011T1 AT 99968140 T AT99968140 T AT 99968140T AT 99968140 T AT99968140 T AT 99968140T AT E302011 T1 ATE302011 T1 AT E302011T1
Authority
AT
Austria
Prior art keywords
ponazuril
abortigenics
coccidia
neurological
treatment
Prior art date
Application number
AT99968140T
Other languages
English (en)
Inventor
Thomas J Kennedy
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE302011T1 publication Critical patent/ATE302011T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99968140T 1998-12-22 1999-12-18 PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN ATE302011T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/218,323 US6150361A (en) 1998-12-22 1998-12-22 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
PCT/US1999/030281 WO2000037063A2 (en) 1998-12-22 1999-12-18 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma

Publications (1)

Publication Number Publication Date
ATE302011T1 true ATE302011T1 (de) 2005-09-15

Family

ID=22814646

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99968140T ATE302011T1 (de) 1998-12-22 1999-12-18 PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN

Country Status (17)

Country Link
US (1) US6150361A (de)
EP (1) EP1140103B1 (de)
JP (1) JP2002532544A (de)
KR (1) KR100661111B1 (de)
CN (1) CN1221265C (de)
AT (1) ATE302011T1 (de)
AU (1) AU764608B2 (de)
BR (1) BR9916391A (de)
CA (1) CA2355825C (de)
DE (1) DE69926794T2 (de)
DK (1) DK1140103T3 (de)
ES (1) ES2247863T3 (de)
HK (1) HK1045266B (de)
HU (1) HUP0104595A3 (de)
NZ (1) NZ512477A (de)
WO (1) WO2000037063A2 (de)
ZA (1) ZA200103920B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1119255A4 (de) 1998-10-08 2009-04-15 New Ace Res Company Neue zusammensetzungen und verfahren zur vorbeugung und behandlung von protozoenerkrankungen
DE19958388A1 (de) * 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
AU2001251761A1 (en) * 2000-04-25 2001-11-07 Wyeth Equine protozoal myeloencephalitis vaccine
DE10040174A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
DE102009012423A1 (de) * 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
WO2024138230A1 (en) * 2022-12-02 2024-06-27 Veterinary Pharmacy Corporation Formulation and method for treatment of infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2718799A1 (de) * 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
US4933341A (en) * 1988-10-08 1990-06-12 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
US5883095A (en) * 1997-08-07 1999-03-16 University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
BR9808114A (pt) * 1997-03-31 2000-03-08 David Granstrom Formulação de ração para cavalos utilizável para tratar epm, processos para tratar pm em um cavalo que necessita deste tratamento, para prevenir infecção com s. neutrona em cavalos, e, para exterminar s. neurona em cavalos
DE19824483A1 (de) * 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
EP1119255A4 (de) * 1998-10-08 2009-04-15 New Ace Res Company Neue zusammensetzungen und verfahren zur vorbeugung und behandlung von protozoenerkrankungen

Also Published As

Publication number Publication date
KR20010080570A (ko) 2001-08-22
HK1045266B (zh) 2006-07-07
WO2000037063A2 (en) 2000-06-29
BR9916391A (pt) 2001-09-18
ZA200103920B (en) 2002-05-15
HUP0104595A2 (hu) 2002-04-29
DE69926794T2 (de) 2006-01-19
CA2355825C (en) 2008-07-08
HUP0104595A3 (en) 2003-10-28
CN1221265C (zh) 2005-10-05
EP1140103B1 (de) 2005-08-17
AU2481700A (en) 2000-07-12
KR100661111B1 (ko) 2006-12-26
JP2002532544A (ja) 2002-10-02
CN1342081A (zh) 2002-03-27
AU764608B2 (en) 2003-08-28
DK1140103T3 (da) 2005-12-19
EP1140103A2 (de) 2001-10-10
WO2000037063A3 (en) 2000-10-19
NZ512477A (en) 2004-05-28
CA2355825A1 (en) 2000-06-29
US6150361A (en) 2000-11-21
DE69926794D1 (de) 2005-09-22
ES2247863T3 (es) 2006-03-01
HK1045266A1 (en) 2002-11-22

Similar Documents

Publication Publication Date Title
AP2004003069A0 (en) 3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof.
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
EA200701296A1 (ru) 3,5-дизамещенные и 3,5,7-тризамещенные 3h-оксазоло- и 3h-тиазоло[4,5-d] пиримидин-2-оны и их пролекарства
DE60331537D1 (de) Kombinationen zur behandlung von multiplem myelom
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
ATE399782T1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
EA200601281A1 (ru) Азабензофуранзамещенные тиомочевины; ингибиторы репликации вирусов
DE69739142D1 (de) Pharmazeutische zusammenstellungen zur prävention und behandlung von zns-erkrankungen
ATE270891T1 (de) Triazinoneverbindungen für die behhandlung von krankheiten verursacht durch neospora und toxoplasma
GB0130677D0 (en) Medicaments and novel compounds
ATE302011T1 (de) PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
EE9900275A (et) CD40L-vastaste ühendite terapeutilise manustamise meetodid
ATE125704T1 (de) Behandlung neurodegenerativer erkrankungen.
BR9916417A (pt) Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasma
DE60108130D1 (de) Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten
EP1050303A3 (de) Methoden und Zusammenstellungen zur Behandlung von altersgebundenen Verhaltensstörungen von Haustieren
DE60115237D1 (de) Praziquantel zusammensetzungen zur behandlung von krankheiten verursacht durch kokzidien
EA200200846A1 (ru) Соединения, полезные для лечения или предупреждения заболеваний, опосредуемых альфа-2в-адреноцептором
UA91697C2 (en) 3, 5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF
MX9704887A (es) Composiciones farmaceuticas para el tratamiento de trastornos depresivos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1140103

Country of ref document: EP

REN Ceased due to non-payment of the annual fee